Neurobiology of Aging
Volume 28, Issue 8 , Pages 1221-1230 , August 2007

Occurrence and co-localization of amyloid β-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice

  • Dietmar Rudolf Thal

      Affiliations

    • Department of Neuropathology, University of Bonn Medical Center, Sigmund Freud Strasse 25, D-53105 Bonn, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 228 287 5775; fax: +49 228 287 4331.
    • ,
  • Sergey Larionov

      Affiliations

    • Department of Neuropathology, University of Bonn Medical Center, Sigmund Freud Strasse 25, D-53105 Bonn, Germany
    • ,
  • Dorothee Abramowski

      Affiliations

    • Novartis Institutes for Biomedical Research Basel, CH-4002 Basel, Switzerland
    • ,
  • Karl-Heinz Wiederhold

      Affiliations

    • Novartis Institutes for Biomedical Research Basel, CH-4002 Basel, Switzerland
    • ,
  • Tom Van Dooren

      Affiliations

    • Department of Human Genetics, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium
    • ,
  • Haruyasu Yamaguchi

      Affiliations

    • Gunma University School of Health Sciences, Maebashi, Gunma 371-8514, Japan
    • ,
  • Christian Haass

      Affiliations

    • Department of Biochemistry, Adolf-Butenandt Institute, Ludwig Maximilians University, D-80336 Munich, Germany
    • ,
  • Fred Van Leuven

      Affiliations

    • Department of Human Genetics, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium
    • ,
  • Matthias Staufenbiel

      Affiliations

    • Novartis Institutes for Biomedical Research Basel, CH-4002 Basel, Switzerland
    • ,
  • Estibaliz Capetillo-Zarate

      Affiliations

    • Department of Neuropathology, University of Bonn Medical Center, Sigmund Freud Strasse 25, D-53105 Bonn, Germany

Received 9 November 2005 ,Revised 18 May 2006 ,Accepted 25 May 2006.

References 

  1. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 1997;17:263–264
  2. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985;76:1501–1513
  3. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA. 1999;96:14088–14093
  4. Duyckaerts C, Dickson DW. Neuropathology of Alzheimer's disease. In:  Dickson D editors. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003;p. 47–65
  5. Frackowiak J, Miller DL, Potempska A, Sukontasup T, Mazur-Kolecka B. Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice. J Neuropathol Exp Neurol. 2003;62:685–696
  6. Frackowiak J, Zoltowska A, Wisniewski HM. Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol. 1994;53:637–645
  7. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995;373:523–527
  8. Glenner GG. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med. 1980;302:1283–1292
  9. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356
  10. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99–102
  11. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, et al. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med. 2000;6:143–150
  12. Kim KS, Miller DL, Sapienza VJ, Chen C-MJ, Bai C, Grundke-Iqbal I, et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun. 1988;2:121–130
  13. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med. 2004;10:719–726
  14. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis. 1996;3:16–32
  15. Masters CL, Beyreuther K. Molecular pathogenesis of Alzheimer's disease. In:  Dickson D editors. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003;p. 69–73
  16. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82:4245–4249
  17. Mazur-Kolecka B, Dickson D, Frackowiak J. Induction of vascular amyloidosis-beta by oxidative stress depends on APOE genotype. Neurobiol Aging. 2006;27:804–814
  18. Mazur-Kolecka B, Frackowiak J, Carroll RT, Wisniewski HM. Accumulation of Alzheimer amyloid-beta peptide in cultured myocytes is enhanced by serum and reduced by cerebrospinal fluid. J Neuropathol Exp Neurol. 1997;56:263–272
  19. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, et al. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA. 2003;100:6221–6226
  20. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541:163–166
  21. Naslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlstrom AR, Bogdanovic N, et al. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron. 1995;15:219–228
  22. Nilsson LN, Arendash GW, Leighty RE, Costa DA, Low MA, Garcia MF, et al. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiol Aging. 2004;25:1153–1167
  23. Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol. 2000;57:869–874
  24. Pollock H, Hutchings M, Weller RO, Zhang ET. Perivascular spaces in the basal ganglia of the human brain: their relationship to lacunes. J Anat. 1997;191(Pt 3):337–346
  25. Russo C, Angelini G, Dapino D, Piccini A, Piombo G, Schettini G, et al. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Proc Natl Acad Sci USA. 1998;95:15598–15602
  26. Sadowski M, Pankiewicz J, Scholtzova H, Ripellino JA, Li Y, Schmidt SD, et al. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. Am J Pathol. 2004;165:937–948
  27. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:9649–9653
  28. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:8098–8102
  29. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA. 1997;94:13287–13292
  30. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, et al. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol. 2002;161:1869–1879
  31. Thal DR, Capetillo-Zarate E, Schultz C, Rüb U, Saido TC, Yamaguchi H, et al. Apolipoprotein E co-localizes with newly formed amyloid ß-protein (Aß)-deposits lacking immunoreactivity against N-terminal epitopes of Aß in a genotype-dependent manner. Acta Neuropathol. 2005;110:459–471
  32. Thal DR, Ghebremedhin E, Rüb U, Yamaguchi H, Del Tredici K, Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2002;61:282–293
  33. Thal DR, Schultz C, Dehghani F, Yamaguchi H, Braak H, Braak E. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. Acta Neuropathol (Berl). 2000;100:608–617
  34. Van Dooren T, Muyllaert D, Borghgraef P, Cresens A, Devijver H, Van der Auwera I, et al. Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice. Am J Pathol. 2006;168:245–260
  35. Weller RO. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol. 1998;57:885–894
  36. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol. 1998;153:725–733
  37. Wild-Bode C, Yamazaki T, Capell A, Leimer U, Steiner H, Ihara Y, et al. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J Biol Chem. 1997;272:16085–16088
  38. Yamaguchi H, Sugihara S, Ogawa A, Saido TC, Ihara Y. Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol (Berl). 1998;95:217–222
  39. Yin Y, Lim YK, Salto-Tellez M, Ng SC, Lin CS, Lim SK. AFP(+), ESC-derived cells engraft and differentiate into hepatocytes in vivo. Stem Cells. 2002;20:338–346
  40. Zhang ET, Richards HK, Kida S, Weller RO. Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol (Berl). 1992;83:233–239

PII: S0197-4580(06)00187-4

doi: 10.1016/j.neurobiolaging.2006.05.029

Neurobiology of Aging
Volume 28, Issue 8 , Pages 1221-1230 , August 2007

Article Tools

* Image Usage & Resolution